Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NewAmsterdam Pharma Co N.V. | Chief Executive Officer, Director | Ordinary Shares | 609K | $9.9M | $16.27 | Aug 20, 2024 | Indirect |
NewAmsterdam Pharma Co N.V. | Chief Executive Officer, Director | Ordinary Shares | 210K | $3.41M | $16.27 | Aug 20, 2024 | Direct |
NewAmsterdam Pharma Co N.V. | Chief Executive Officer, Director | Warrant (right to buy) | 85K | $978K | $11.50 | Oct 9, 2024 | Direct |
CALADRIUS BIOSCIENCES, INC. | Director | Common Stock | 210K | $627K | $2.99 | Jan 10, 2022 | Direct |
NewAmsterdam Pharma Co N.V. | Chief Executive Officer, Director | Option (right to buy) | 1.04M | Jan 1, 2024 | Direct | ||
TENAX THERAPEUTICS, INC. | Director | Pre-Funded Warrant | 47.5K | Aug 8, 2024 | Direct | ||
BioAge Labs, Inc. | Director | Stock Option (Right to Buy) | 34K | Mar 26, 2024 | Direct | ||
TENAX THERAPEUTICS, INC. | Director | Warrant | 25K | Aug 8, 2024 | Direct | ||
TENAX THERAPEUTICS, INC. | Director | Common Stock | 2.88K | Aug 8, 2024 | Direct | ||
TENAX THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 4 | Aug 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NAMS | NewAmsterdam Pharma Co N.V. | Oct 9, 2024 | 1 | -$173K | 4 | Oct 11, 2024 | Chief Executive Officer, Director |
BIOA | BioAge Labs, Inc. | Sep 25, 2024 | 0 | $0 | 3 | Sep 25, 2024 | Director |
NAMS | NewAmsterdam Pharma Co N.V. | Aug 20, 2024 | 1 | $81.4K | 4 | Aug 22, 2024 | Chief Executive Officer, Director |
TENX | TENAX THERAPEUTICS, INC. | Aug 8, 2024 | 3 | $0 | 4 | Aug 8, 2024 | Director |
NAMS | NewAmsterdam Pharma Co N.V. | Jun 20, 2024 | 1 | $86.3K | 4 | Jun 24, 2024 | Chief Executive Officer, Director |
BIOA | BioAge Labs, Inc. | Mar 26, 2024 | 2 | $0 | 4 | Sep 27, 2024 | Director |
NAMS | NewAmsterdam Pharma Co N.V. | Jan 1, 2024 | 1 | $0 | 4 | Jan 3, 2024 | Chief Executive Officer, Director |
NAMS | NewAmsterdam Pharma Co N.V. | Dec 29, 2023 | 0 | $0 | 3/A | Jan 25, 2024 | Chief Executive Officer, Director |
NAMS | NewAmsterdam Pharma Co N.V. | Dec 29, 2023 | 0 | $0 | 3 | Dec 29, 2023 | Chief Executive Officer, Director |
TENX | TENAX THERAPEUTICS, INC. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
LSTA | CALADRIUS BIOSCIENCES, INC. | Jan 10, 2022 | 1 | $0 | 4 | Jan 12, 2022 | Director |
TENX | TENAX THERAPEUTICS, INC. | Jun 11, 2021 | 3 | $0 | 4 | Jun 15, 2021 | Director |
TENX | TENAX THERAPEUTICS, INC. | Feb 25, 2021 | 0 | $0 | 3 | Jun 15, 2021 | Director |